Full-Time

Compensation Analyst

Care Access

Care Access

501-1,000 employees

Global health education, access, and research

No salary listed

No H1B Sponsorship

Remote in USA

Remote

Less than 10% travel required.

Category
People & HR (1)
Required Skills
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Strong to advanced MS Office Excel skills
  • An understanding of general compensation practices including job evaluation and market pricing
  • Excellent interpersonal skills with the ability to handle sensitive and confidential situations with tact, professionalism, and diplomacy
  • Self-starter with an ability to work independently
  • Detail oriented individual with the capability of handling multiple projects at any given time
  • Bachelor’s degree in business administration, accounting/finance, or human resources preferred
  • 2-3 years of professional work experience preferably in Total Rewards, HR Analytics, or Finance
  • CCP coursework preferred
Responsibilities
  • Support with the annual merit, promotion, and bonus planning process
  • Utilize market data and internal pay comparisons to provide compensation recommendations for new positions, internal moves, and market reviews
  • Complete market benchmarking of jobs and participate in salary surveys
  • Partner with business leaders on the management and administration of short-term incentive plans
  • Support the business with job description creation and maintenance ensuring compliance with local regulations and FLSA standards
  • Act as advisor to external partners supporting compensation initiatives
  • Provide general reporting and data analytics support to HR cross functional teams including HR Operations and Talent
  • Other job duties as assigned
Desired Qualifications
  • CCP coursework preferred

Care Access coordinates global efforts to improve health by educating people about health, helping them access needed resources, and enabling participation in medical research to develop new medicines and cures. Its approach involves a global network and services that educate individuals, connect them with health resources, and recruit participants for clinical studies, thereby supporting the development of new treatments. Unlike companies that focus on a single market or product, Care Access operates worldwide and focuses on easing access to information, services, and research opportunities for diverse populations. The goal is to make health information and access more available and participation in health studies easier, with the aim of making the future of health better for everyone.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Boston, Massachusetts

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Walmart partnership expands recruitment via 4,700 stores, targeting underserved rural and minority communities.
  • Warsaw, Poland site launch strengthens European footprint amid rare disease trial growth in 2026.
  • FDA 2025 guidance boosts decentralized trials, amplifying Care Access's remote monitoring infrastructure.

What critics are saying

  • Walmart Healthcare Research Institute replicates Care Access model across stores, eroding patient pipeline by 2028.
  • Care Access Research lawsuit disrupts thousands of participants, halting enrollments through 2026 deadlines.
  • Warsaw site misses targets from Syneos Health competition and regulations within 12 months.

What makes Care Access unique

  • Care Access opens clinical research sites inside Walmart stores in Houston, Tyler, and Dalton starting Spring 2026.
  • Frontiers in Medicine study proves Care Access's community model achieves higher randomization rates than traditional sites.
  • Care Access deploys mobile clinics and Sites On Demand to deliver trials directly in local communities.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Care Access who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Company News

SmartBrief
Jan 22nd, 2026
Walmart, Care Access to partner on clinical research

Walmart, Care Access to partner on clinical research. Walmart will partner with Care Access to launch a clinical research initiative this spring that will bring clinical trial opportunities to markets, including rural areas that often lack access to cutting-edge medical research. The retailer will open research sites at select stores and former Walmart Health clinic locations. By using familiar community spaces, Walmart hopes to make participation in clinical research more accessible and convenient for local residents. Designed specifically for retail professionals, NRF SmartBrief is a free, daily email newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition.

First Free Church Chicago
Dec 1st, 2024
Care Access Senior Fair | December 6 + 7

On December 6th and 7th Firstfree is partnering with Care Access, an organization with a mission to connect the community with equitable health research.

Business Wire
Mar 18th, 2024
Care Access Opens New Clinical Research Site In Warsaw, Poland

BOSTON--(BUSINESS WIRE)--Care Access, a global clinical research site company helping to accelerate the future of medicine, has opened its newest research site in Warsaw, Poland. The company’s expansion in Poland reinforces its commitment to improving access to clinical research globally through its innovative model of bringing clinical trials wherever they are needed. In recent years, Care Access has been active in clinical research across Europe, and now, by establishing a new facility in Warsaw, Care Access is further expanding its European services aimed to implement its industry-leading research capabilities, such as its Community Screening Program, Sites On Demand, and Mobile Research Site Infrastructure. These capabilities have shown to accelerate research study enrollment by adapting to the unique makeup of each community and providing more convenient ways to participate in clinical trials. “Poland plays an important role in bringing the future of medicine to reality,” said Rupi Bancil, Senior Vice President of Global Study Operations Expansion for Care Access. “The Warsaw site will improve access to advanced health screenings and research opportunities to communities throughout Poland.”

Business Wire
Mar 4th, 2024
New Study Addressing Global Concern For Breast Cancer Treatment Now Available In Clifton, N.J.

BOSTON--(BUSINESS WIRE)--A cancer research study focusing on hormone receptor-positive HER2-negative (HR+/HER2-) metastatic breast cancer (MBC) is now available to patients in the Clifton, N.J., area. The SERENA-6 trial, sponsored by AstraZeneca, is a global study that aims to address a critical issue faced by many patients: their treatments become less effective over time. In advanced breast cancer, patients receive a treatment that combines an estrogen-reducing drug with a drug that slows cancer cell growth. While this combination works well, over time, it may stop working because of mutations in the ESR1 gene. This study will evaluate if an experimental trial drug, combined with a cancer-slowing drug, might work better than conventional estrogen-reducing drugs for patients with ESR1 mutations

Business Wire
Feb 27th, 2024
New Research Study For Patients With Ulcerative Colitis Now Available In Ogden, Utah

BOSTON--(BUSINESS WIRE)--Adults in the Ogden, Utah area with moderately to severely active ulcerative colitis (UC) may have the opportunity to join a research study assessing a new investigational medication. UC is the most common form of inflammatory bowel disease (IBD), affecting an estimated 5 million people worldwide. There is no known cure for UC, though new therapies have become available in recent years that offer patients improved treatment options. Current treatments for UC offer relief for many individuals, but some still face recurrent flare-ups or undesirable side effects. The ANTHEM-UC study from Janssen Research Development seeks to assess if an investigational pill could help those patients whose UC is not adequately managed by currently available therapies. “Ulcerative colitis is a lifelong condition that often gets worse over time, potentially causing severe flare-ups or hospitalization,” said Dr